These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6135 related articles for article (PubMed ID: 3292617)

  • 1. Depigmenting potency of hydroquinone fatty acid esters on the skin.
    Hashimoto A; Hasegawa K; Asai T; Masamoto Y; Ichihashi M; Mishima Y
    J Dermatol; 1988 Feb; 15(1):37-43. PubMed ID: 3292617
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
    Bolognia JL; Sodi SA; Osber MP; Pawelek JM
    Br J Dermatol; 1995 Sep; 133(3):349-57. PubMed ID: 8546987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of depigmentation by hydroquinone: a study on suppression and recovery processes of tyrosinase activity in the pigment cells in vivo and in vitro].
    Hashimoto A; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1984 Jun; 94(7):797-804. PubMed ID: 6436557
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
    Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
    Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes.
    Penney KB; Smith CJ; Allen JC
    J Invest Dermatol; 1984 Apr; 82(4):308-10. PubMed ID: 6200545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection?
    Kasraee B; Handjani F; Aslani FS
    Dermatology; 2003; 206(4):289-91. PubMed ID: 12771467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UVB-induced pigmentation in hairless mice as an in vivo assay for topical skin-depigmenting activity.
    Nair X; Tramposch KM
    Skin Pharmacol; 1989; 2(4):187-97. PubMed ID: 2638867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depigmenting action of phenylhydroquinone, an O-phenylphenol metabolite, on the skin of JY-4 black guinea-pigs.
    Tayama K; Takahama M
    Pigment Cell Res; 2002 Dec; 15(6):447-53. PubMed ID: 12453187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depigmenting chemical agents].
    Ortonne JP
    Ann Dermatol Venereol; 1986; 113(8):733-6. PubMed ID: 3800227
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monobenzylether of hydroquinone.
    Bentley-Phillips B
    Br J Dermatol; 1978 Dec; 99(6):719. PubMed ID: 737135
    [No Abstract]   [Full Text] [Related]  

  • 12. Further antineoplastic terpenylquinones and terpenylhydroquinones.
    Miguel del Corral JM; Gordaliza M; Castro MA; Mahiques MM; San Feliciano A; García-Grávalos MD
    Bioorg Med Chem; 1998 Jan; 6(1):31-41. PubMed ID: 9502103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin depigmentation by hydroquinone: a chemical and biochemical insight.
    Palumbo A; d'Ischia M; Misuraca G; Prota G
    Pigment Cell Res; 1992; Suppl 2():299-303. PubMed ID: 1409433
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
    J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
    Hernick M; Flader C; Borch RF
    J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery.
    Candan G; Michiue H; Ishikawa S; Fujimura A; Hayashi K; Uneda A; Mori A; Ohmori I; Nishiki T; Matsui H; Tomizawa K
    Biomaterials; 2012 Sep; 33(27):6468-75. PubMed ID: 22743600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals.
    Anwar AI; Wahab S; Widita W; Nurdin AR; Budhiani S; Seweng A
    Dermatol Ther; 2019 Nov; 32(6):e13146. PubMed ID: 31664751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents.
    Hu ZM; Zhou Q; Lei TC; Ding SF; Xu SZ
    J Dermatol Sci; 2009 Sep; 55(3):179-84. PubMed ID: 19574027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 307.